Trump Administration Invites Health Care Industry to Help Rewrite Ban on Kickbacks

By ROBERT PEAR
NYT Politics
The goal is to open pathways for doctors and hospitals to work together to improve care and save money. The challenge will be to accomplish that without also increasing the risk of fraud.
Published date: November 24, 2018 at 04:51PM
The New York Times
New York Times article

Medicare Advantage Plans Found to Improperly Deny Many Claims

By ROBERT PEAR
NYT Politics
The popular plans, which now cover more than 20 million people, have an incentive to deny claims “in an attempt to increase their profits,” a report says.
Published date: October 13, 2018 at 03:14PM
The New York Times
New York Times article

Fact-Checking the President: Has He Saved or Sabotaged Obamacare?

By ROBERT PEAR
NYT Politics
President Trump boasts that he has “mostly obliterated Obamacare.” His health secretary is taking credit for making the law work better than ever. Who’s right?
Published date: October 6, 2018 at 04:44PM
The New York Times
New York Times article

As Catholic Hospitals Expand, So Do Limits on Some Procedures

By KATIE HAFNER
NYT
Many religious health care institutions do not make it clear up front what procedures they won’t perform, a New York Times analysis shows.
Published date: August 10, 2018 at 05:54PM
The New York Times
New York Times article

Meet the Rebate, the New Villain of High Drug Prices

By KATIE THOMAS
NYT
A growing chorus, including the Trump administration, is calling for a rethinking of after-the-fact drug discounts that some say contribute to rising prices.
Published date: July 27, 2018 at 07:36PM
The New York Times
New York Times article

Merck to Lower Prices on Some Drugs, but Not its Blockbusters

By KATIE THOMAS
NYT
The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection.
Published date: July 20, 2018 at 01:19AM
The New York Times
New York Times article

Requiring Prices in Drug Ads: Would It Do Any Good? Is It Even Legal?

By ROBERT PEAR
NYT Politics
A proposal that the administration presents as a matter of transparency has raised a torrent of questions from consumers, doctors, drugmakers and advertising professionals.
Published date: May 19, 2018 at 04:15PM
The New York Times
New York Times article